Header Logo

Connection

HELEN PIWNICA-WORMS to Drug Synergism

Back to Details
This is a "connection" page, showing publications HELEN PIWNICA-WORMS has written about Drug Synergism.
HELEN PIWNICA-WORMS
Connection Strength
0.028
Drug Synergism
  1. CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib. Cancer Res. 2017 07 15; 77(14):3870-3884.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.